Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
6,506.48
(
-1.51%
)
US TECH 100
23,484.80
(
-0.99%
)
Dow Jones
45,577.47
(
-0.96%
)
Brent Oil
106.93
(
0.00%
)
Bitcoin
70,644.01
(
0.18%
)
News Focus
News Focus
Post# of 257267
Next 10
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

oc631

Send PM Follow Ignore
Followers 15
Posts 1749
Boards Moderated 0
Alias Born 08/12/2007

oc631

Re: DewDiligence post# 171550

Thursday, 12/19/2013 10:10:46 AM

Thursday, December 19, 2013 10:10:46 AM

Post# of 257267

They had no choice; if GILD hadn’t tested an 8-week regimen in at least one phase-3 trial, the backlash from patient advocacy groups and third-party payers would’ve been severe and likely caused economic harm.




Just because it's a 8-week regimen doesn't guarantee advocacy groups will be happy with the price.

Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Discover What Traders Are Watching

Explore small cap ideas before they hit the headlines.

Join Today